Overview
KRYS market data
Price History
KRYS price chart · 1M
- O
- 328.63
- H
- 332.50
- L
- 320.81
- C
- 327.13
- Vol
- 19,205.00
Daily history from Sep 20, 2017
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $328.63
- Previous Close
- $334.84
- Day High
- $332.50
- Day Low
- $320.81
- 52 Week High
- $382.01
- 52 Week Low
- $180.12
- 7 Day Return
- -2.36%
- 30 Day Return
- -6.91%
- 90 Day Return
- -12.83%
- 1 Year Return
- +81.25%
- Daily Notional Volume
- $6.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 39.74 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.84 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.65 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 54.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $179.16 – $382.54 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $9.6B · P/B 5.86 · P/S 21.78.
Company News
10 captured
Krystal Biotech to Present at 2026 Cantor Global Healthcare ConferenceGlobenewswire Inc ·
Krystal Biotech shares are trading lower after the company announced mixed Q2 financial results.Benzinga ·
8-K filing — Krystal Biotech, Inc. (KRYS)SEC EDGAR ·
Krystal Biotech Q2 EPS $1.79 Beats $1.66 Estimate, Sales $119.222M Miss $121.061M EstimateBenzinga ·
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026Globenewswire Inc ·
Why Tutor Perini Stock Trounced the Market on TuesdayThe Motley Fool ·